Ashigarakami-gun, Japan

Takuya Matsumoto


 


Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2015-2020

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):

Title: Takuya Matsumoto: Innovator in Thionucleoside Research

Introduction

Takuya Matsumoto is a prominent inventor based in Ashigarakami-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thionucleosides. With a total of 7 patents to his name, Matsumoto's work has the potential to impact cancer treatment significantly.

Latest Patents

Matsumoto's latest patents include a synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine and a synthetic intermediate of thionucleoside. These compounds are crucial for producing thionucleosides, which are valuable in pharmaceutical applications. His work also includes a thionucleoside derivative or salt thereof, along with a pharmaceutical composition that demonstrates excellent efficacy against tumors, particularly those resistant to gemcitabine.

Career Highlights

Throughout his career, Takuya Matsumoto has worked with notable companies such as Fujifilm Corporation and Mitsui Chemicals Asahi Life Materials Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Matsumoto has collaborated with esteemed colleagues, including Kouki Nakamura and Satoshi Shimamura. These partnerships have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.

Conclusion

Takuya Matsumoto is a distinguished inventor whose work in thionucleoside research holds promise for future cancer therapies. His contributions to the field are noteworthy, and his patents reflect his commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…